Alison Milhous
Förmögenhet: 4 219 $ per 2026-09-30
Förmögenhet: 4 219 $ per 2026-09-30
Alison Tjosvold Milhous is currently an Independent Director at VivoSim Labs, Inc. since 2020 and Vice President-Accounting at Erasca, Inc. since 2021.
Formerly, Ms. Milhous was an Audit Partner at Grant Thornton LLP from 2015 to 2019.
Education includes undergraduate studies at California Polytechnic State University (San Luis Obispo).
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
VIVOSIM LABS INC 0,77 % | 2026-08-13 | 19 899 ( 0,77 % ) | 4 219 $ | 2026-09-30 |
| Företag | Position | Start |
|---|---|---|
| VIVOSIM LABS, INC. | Direktör/Styrelseledamot | 2020-09-15 |
| ERASCA, INC. | Comptroller/Controller/Revisor | 2021-11-01 |
| Företag | Position | Slut |
|---|---|---|
Grant Thornton LLP
Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting, assurance, tax and advisory services | Företagsledare/Principal | 2019-09-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
VivoSim Labs, Inc.
VivoSim Labs, Inc. BiotechnologyHealth Technology Engages in developing and commercializing functional human tissues | Health Technology |
Grant Thornton LLP
Grant Thornton LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting, assurance, tax and advisory services | Commercial Services |
California Polytechnic State University (San Luis Obispo)
California Polytechnic State University (San Luis Obispo) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Erasca, Inc.
Erasca, Inc. Pharmaceuticals: MajorHealth Technology Develops, discovers and commercializes therapies for RAS/MAPK pathway-driven cancers | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån